Clinical Trial Update: Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for a combination of alpelisib and trametinib in progressive refractory meningiomas; study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• MEKINIST (trametinib)
• Piqray (alpelisib)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Meningioma | Phase 1 | Status: RECRUITING